According to the The Journal of Nuclear Medicine, a new class of radiopharmaceuticals has been developed to non-invasively identify over 30 types of malignant cancerous tumors.The latest Radiotracer uses a modified PET/CT scan (positron emission tomography/computed tomography) to image a large variety of tumors in various stages with high image contrast, paving the way for dozens of potential applications in …